Qualigen gains on extension of deadline to meet Nasdaq listing norms

Aixcrypto Holdings

02/09/2022 14:10

** Shares of Qualigen Therapeutics Inc  QLGN.O  rise 3.3% to
39 cents premarket
    ** Co says in a filing that it has received a further
180-day extension from Nasdaq to regain compliance with minimum
bid price requirement till Feb. 27, 2023 
    ** In March, co received a notice from Nasdaq for not
meeting the requirement 
    ** The notice is served when listed securities fail to
maintain minimum bid price of $1/shr for 30 consecutive business
days; shares could be delisted on not meeting the requirements
    ** As of last close, stock down ~65% YTD

 (Reporting by Raghav Mahobe)
 ((Raghav.Mahobe@thomsonreuters.com;))